The first quarter concluded with a record-breaking $1.3 trillion in global M&A transactions, signaling strong confidence in the deal-making environment despite market volatility.
SpaceX has confidentially filed for what could be the largest IPO ever, seeking to raise up to $75 billion at a valuation of $1.75 trillion, with a potential listing as early as June.
A 'K-shaped' recovery is evident in venture capital, with AI-focused companies like OpenAI, Periodic Labs, and Hippocratic AI raising massive funding rounds at soaring valuations, while non-AI startups face a more constrained environment.
Major corporations like Unilever, Biogen, and Eli Lilly are actively reshaping their portfolios through strategic M&A, divesting slower-growth assets to focus on core, high-growth areas like personal care and specialized pharmaceuticals.
12 quotes
Concerns Raised
Market volatility driven by geopolitical events like the war in Iran.
The widening capital gap between AI and non-AI companies in the venture market.
Potential liquidity stress in private credit products (BDCs) if redemption requests increase.
Opportunities Identified
The landmark SpaceX IPO, which could be the largest in history.
A robust M&A environment driven by corporate portfolio reshaping and available financing.
Investing in AI companies that apply technology to transform traditional industries like healthcare and logistics.
The expansion of private market assets into retail investor portfolios.